Cancer and neoplasms
Influence of lymphadenectomy on survival and recurrence in patients with early-stage epithelial ovarian cancer: a meta-analysis
Sep
Viale PH. The American Cancer Society’s facts & figures: 2020 Edition. J Adv Practitioner Oncol. 2020;11(2):135–6.
Wang Z, Guo E, Yang B, Xiao R, Lu F, You L, Chen G. Trends and age-period-cohort effects on mortality of the three major gynecologic cancers in China from 1990 to 2019: cervical, ovarian and uterine cancer. Gynecol Oncol. 2021;163(2):358–63.
Google Scholar
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209–49.
Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, Gaudet MM, Jemal A, Siegel RL. Ovarian cancer statistics, 2018. Cancer J Clin. 2018;68(4):284–96.
Deng T, Huang Q, Wan T, Luo X, Feng Y, Huang H, Liu J. The impact of lymph node dissection on survival in patients with clinical early-stage ovarian cancer. J Gynecol Oncol. 2021;32(3):e40.
Google Scholar
Heitz F, Harter P, Ataseven B, Heikaus S, Schneider S, Prader S, Bommert M, Fisseler-Eckhoff A, Traut A, du Bois A. Stage- and histologic subtype-dependent frequency of Lymph Node Metastases in patients with epithelial ovarian Cancer undergoing systematic pelvic and paraaortic lymphadenectomy. Ann Surg Oncol. 2018;25(7):2053–9.
Google Scholar
Li T, Liu Y, Xie S, Wang H. Systematic pelvic and para-aortic lymphadenectomy during fertility-sparing surgery in patients with early-stage epithelial ovarian Cancer: a retrospective study. Front Oncol. 2022;12:913103.
Google Scholar
Yoshihara M, Tamauchi S, Iyoshi S, Kitami K, Uno K, Tano S, Matsui S, Kajiyama H. Does complete-staging lymphadenectomy improve survival outcomes in stage I endometrioid epithelial ovarian carcinoma? A multi-institutional retrospective study with propensity score-weighted analysis. Jpn J Clin Oncol. 2021;51(3):387–92.
Google Scholar
Bizzarri N, du Bois A, Fruscio R, De Felice F, De Iaco P, Casarin J, Vizza E, Chiantera V, Corrado G, Cianci S, et al. Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer? Gynecol Oncol. 2021;160(1):56–63.
Google Scholar
Chiyoda T, Sakurai M, Satoh T, Nagase S, Mikami M, Katabuchi H, Aoki D. Lymphadenectomy for primary ovarian cancer: a systematic review and meta-analysis. J Gynecol Oncol. 2020;31(5):e67.
Google Scholar
Gao J, Yang X, Zhang Y. Systematic lymphadenectomy in the treatment of epithelial ovarian cancer: a meta-analysis of multiple epidemiology studies. Jpn J Clin Oncol. 2015;45(1):49–60.
Google Scholar
Lin Q, Liu W, Xu S, Li J, Tong J. The value of systematic lymphadenectomy during debulking surgery in the treatment of ovarian cancer: a meta-analysis of randomized controlled trials. J Ovarian Res. 2020;13(1):56.
Google Scholar
Zhou J, Shan G, Chen Y. The effect of lymphadenectomy on survival and recurrence in patients with ovarian cancer: a systematic review and meta-analysis. Jpn J Clin Oncol. 2016;46(8):718–26.
Google Scholar
Kim HS, Ju W, Jee BC, Kim YB, Park NH, Song YS, Kim SC, Kang SB, Kim JW. Systematic lymphadenectomy for survival in epithelial ovarian cancer: a meta-analysis. Int J Gynecol cancer: Official J Int Gynecol Cancer Soc. 2010;20(4):520–8.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
Google Scholar
Lo CK-L, Mertz D, Loeb M. Newcastle-Ottawa Scale: comparing reviewers’ to authors’ assessments. BMC Med Res Methodol. 2014;14:45.
Google Scholar
Tarsilla M. Cochrane Handbook for systematic reviews of interventions. J Multidisciplinary Evaluation. 2008;6:142–8.
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.
Google Scholar
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.
Google Scholar
Matsuo K, Machida H, Mariani A, Mandelbaum RS, Glaser GE, Gostout BS, Roman LD, Wright JD. Adequate pelvic lymphadenectomy and survival of women with early-stage epithelial ovarian cancer. J Gynecol Oncol. 2018;29(5):e69.
Google Scholar
Abe A, Furumoto H, Irahara M, Ino H, Kamada M, Naka O, Sasaki M, Kagawa T, Okitsu O, Kushiki N. The impact of systematic para-aortic and pelvic lymphadenectomy on survival in patients with optimally debulked ovarian cancer. J Obstet Gynaecol Res. 2010;36(5):1023–30.
Google Scholar
Chen Q, Wang S, Lang JH. The impact of lymph node dissection on apparent stage I epithelial ovarian carcinoma: a population-based study. Int J Gynaecol Obstet. 2021;154(3):550–7.
Google Scholar
Ho CM, Chien TY, Shih BY, Huang SH. Evaluation of complete surgical staging with pelvic and para-aortic lymphadenectomy and paclitaxel plus carboplatin chemotherapy for improvement of survival in stage I ovarian clear cell carcinoma. Gynecol Oncol. 2003;88(3):394–9.
Google Scholar
Maggioni A, Benedetti Panici P, Dell’Anna T, Landoni F, Lissoni A, Pellegrino A, Rossi RS, Chiari S, Campagnutta E, Greggi S, et al. Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis. Br J Cancer. 2006;95(6):699–704.
Google Scholar
Nasioudis D, Haggerty AF, Giuntoli RL 2nd, Burger RA, Morgan MA, Ko EM, Latif NA. Adjuvant chemotherapy is not associated with a survival benefit for patients with early stage mucinous ovarian carcinoma. Gynecol Oncol. 2019;154(2):302–7.
Google Scholar
Oshita T, Itamochi H, Nishimura R, Numa F, Takehara K, Hiura M, Tanimoto H, Noma J, Hayase R, Murakami A, et al. Clinical impact of systematic pelvic and para-aortic lymphadenectomy for pT1 and pT2 ovarian cancer: a retrospective survey by the Sankai Gynecology Study Group. Int J Clin Oncol. 2013;18(6):1107–13.
Google Scholar
Svolgaard O, Lidegaard O, Nielsen ML, Nedergaard L, Mosgaard BJ, Lidang M, Mogensen O, Kock K, Blaakaer J, Staehr E, et al. Lymphadenectomy in surgical stage I epithelial ovarian cancer. Acta Obstet Gynecol Scand. 2014;93(3):256–60.
Google Scholar
Yamazaki H, Todo Y, Shimada C, Takeshita S, Minobe S, Okamoto K, Yamashiro K, Kato H. Therapeutic significance of full lymphadenectomy in early-stage ovarian clear cell carcinoma. J Gynecol Oncol. 2018;29(2):e19.
Google Scholar
Yoshihara M, Kajiyama H, Tamauchi S, Iyoshi S, Yokoi A, Suzuki S, Kawai M, Nagasaka T, Takahashi K, Matsui S, et al. Prognostic impact of pelvic and para-aortic lymphadenectomy on clinically-apparent stage I primary mucinous epithelial ovarian carcinoma: a multi-institutional study with propensity score-weighted analysis. Jpn J Clin Oncol. 2020;50(2):145–51.
Google Scholar
Zhao Y, Wang S, Qu YM, Ji YT, Shen K, Lang JH. Prognostic analysis for chinese patients with stage I ovarian endometrioid carcinoma. J Ovarian Res. 2017;10(1):63.
Google Scholar
Kleppe M, Wang T, Van Gorp T, Slangen BFM, Kruse AJ, Kruitwagen RFPM. Lymph node metastasis in stages I and II ovarian cancer: a review. Gynecol Oncol. 2011;123(3):610–4.
Google Scholar
Kossaï M, Leary A, Scoazec J-Y, Genestie C. Ovarian Cancer: a heterogeneous disease. Pathobiology. 2018;85(1–2):41–9.
Google Scholar
Imterat M, Harter P. Early-stage epithelial ovarian cancer: is systematic lymph node staging mandatory? J Gynecologic Oncol. 2021;32(4):e61.
Kleppe M, van der Aa MA, Van Gorp T, Slangen BF, Kruitwagen RF. The impact of lymph node dissection and adjuvant chemotherapy on survival: a nationwide cohort study of patients with clinical early-stage ovarian cancer. Eur J Cancer. 2016;66:83–90.
Google Scholar
Powless CA, Aletti GD, Bakkum-Gamez JN, Cliby WA. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging. Gynecol Oncol. 2011;122(3):536–40.
Google Scholar
Benedetti Panici P, Giannini A, Fischetti M, Lecce F, Di Donato V. Lymphadenectomy in Ovarian Cancer: is it still justified? Curr Oncol Rep. 2020;22(3):22.
Google Scholar
Harter P, Sehouli J, Lorusso D, Reuss A, Vergote I, Marth C, Kim J-W, Raspagliesi F, Lampe B, Aletti G, et al. A Randomized Trial of Lymphadenectomy in patients with Advanced Ovarian Neoplasms. N Engl J Med. 2019;380(9):822–32.
Google Scholar
Lheureux S, Gourley C, Vergote I, Oza AM. Epithelial ovarian cancer. Lancet. 2019;393(10177):1240–53.
Google Scholar
Ramalingam P. Morphologic, immunophenotypic, and molecular features of epithelial ovarian Cancer. Oncol (Williston Park). 2016;30(2):166–76.
Falcetta FS, Medeiros LR, Edelweiss MI, Pohlmann PR, Stein AT, Rosa DD. Adjuvant platinum-based chemotherapy for early stage cervical cancer. Cochrane Database Syst Rev. 2016;11:CD005342.
Google Scholar
Oseledchyk A, Leitao MM, Konner J, O’Cearbhaill RE, Zamarin D, Sonoda Y, Gardner GJ, Long Roche K, Aghajanian CA, Grisham RN, et al. Adjuvant chemotherapy in patients with stage I endometrioid or clear cell ovarian cancer in the platinum era: a Surveillance, Epidemiology, and end results Cohort Study, 2000–2013. Ann Oncol. 2017;28(12):2985–93.
Google Scholar
Di Donato V, Giannini A, D’Oria O, Schiavi MC, Di Pinto A, Fischetti M, Lecce F, Perniola G, Battaglia F, Berloco P, et al. Hepatobiliary disease resection in patients with Advanced Epithelial Ovarian Cancer: Prognostic Role and Optimal Cytoreduction. Ann Surg Oncol. 2021;28(1):222–30.
Google Scholar
Matsuo K, Klar M, Nusbaum DJ, Hasanov MF, Vallejo A, Ciesielski KM, Muderspach LI, Roman LD, Wright JD. Utilization and outcomes of Sentinel Lymph Node Biopsy for Early Endometrial Cancer. Obstet Gynecol. 2022;139(5):809–20.
Google Scholar
Niikura H, Tsuji K, Tokunaga H, Shimada M, Ishikawa M, Yaegashi N. Sentinel node navigation surgery in cervical and endometrial cancer: a review. Jpn J Clin Oncol. 2019;49(6):495–500.
Google Scholar
Lago V, Bello P, Montero B, Matute L, Padilla-Iserte P, Lopez S, Marina T, Agudelo M, Domingo S. Sentinel lymph node technique in early-stage ovarian cancer (SENTOV): a phase II clinical trial. Int J Gynecol cancer: Official J Int Gynecol Cancer Soc. 2020;30(9):1390–6.
